XML 31 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Changes in Equity - USD ($)
$ in Millions
Total
Abingworth
Common Stock
Common Stock
Abingworth
Additional Paid-in Capital
Additional Paid-in Capital
Abingworth
Retained Earnings (Deficit)
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interests in Consolidated Entities
Beginning balance (in shares) at Dec. 31, 2021     355,400,000            
Beginning balance at Dec. 31, 2021 $ 5,706.2   $ 3.6   $ 2,717.6   $ 2,805.3 $ (247.5) $ 427.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased (in shares)     (5,000,000.0)            
Shares repurchased (185.6)           (185.6)    
Equity-based compensation 162.5       162.5        
Net shares issued for equity-based awards (in shares)     6,200,000            
Shares issued for performance allocations (in shares)     900,000            
Shares issued for performance allocations 38.9       38.9        
Shares issued related to the acquisition of CBAM and Abingworth (in shares)     4,200,000 600,000          
Shares issued related to the acquisition of CBAM and Abingworth 194.5 $ 25.0     194.5 $ 25.0      
Contributions 391.2               391.2
Dividends and distributions (660.4)           (443.6)   (216.8)
Net income 1,284.7           1,225.0   59.7
Deconsolidation of Consolidated Entities (47.6)               (47.6)
Non-controlling interests related to the acquisition of Abingworth 4.2               4.2
Currency translation adjustments (107.8)             (90.2) (17.6)
Defined benefit plans, net 15.5             15.5  
Ending balance (in shares) at Dec. 31, 2022     362,300,000            
Ending balance at Dec. 31, 2022 $ 6,821.3   $ 3.6   3,138.5   3,401.1 (322.2) 600.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased (in shares) (6,505,037)   (6,500,000)            
Shares repurchased $ (203.5)           (203.5)    
Equity-based compensation 255.1       255.1        
Net shares issued for equity-based awards (in shares)     5,500,000            
Dividend-equivalent rights on certain equity-based awards 0.0       9.4   (9.4)    
Contributions 177.0               177.0
Dividends and distributions (637.4)           (497.7)   (139.7)
Net income (496.7)           (608.4)   111.7
Deconsolidation of Consolidated Entities (168.8)               (168.8)
Currency translation adjustments 41.7             29.1 12.6
Defined benefit plans, net $ (4.2)             (4.2)  
Ending balance (in shares) at Dec. 31, 2023 361,326,172   361,300,000            
Ending balance at Dec. 31, 2023 $ 5,784.5   $ 3.6   3,403.0   2,082.1 (297.3) 593.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased (in shares) (8,984,957)   (9,000,000.0)            
Shares repurchased $ (395.7)   $ (0.1)       (395.6)    
Equity-based compensation 476.2   $ 0.1   476.1        
Net shares issued for equity-based awards (in shares)     4,900,000            
Net shares issued for equity-based awards (159.0)           (159.0)    
Dividend-equivalent rights on certain equity-based awards 0.0       13.2   (13.2)    
Contributions 319.5               319.5
Dividends and distributions (681.4)           (503.0)   (178.4)
Net income 1,091.1           1,020.4   70.7
Change in ownership of a Consolidated Entity 0.0           9.1   (9.1)
Deconsolidation of Consolidated Entities (50.4)               (50.4)
Currency translation adjustments (39.8)             (35.1) (4.7)
Defined benefit plans, net $ 2.6             2.6  
Ending balance (in shares) at Dec. 31, 2024 357,183,632   357,200,000            
Ending balance at Dec. 31, 2024 $ 6,347.6   $ 3.6   $ 3,892.3   $ 2,040.8 $ (329.8) $ 740.7